共 7 条
[1]
Chang JY(2012)Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer Radiat Oncol 7 152-637
[2]
Chang JY(2015)Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 630-386
[3]
Crabtree TD(2010)Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 377-244
[4]
Palma D(2011)Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery Radiother Oncol 101 240-1253
[5]
Shirvani SM(2014)Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly JAMA Surg 149 1244-1548
[6]
Verstegen NE(2013)Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis Ann Oncol 24 1543-301
[7]
Videtic GMM(2017)Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline Pract Radiat Oncol 7 295-undefined